Myriad Assures Investors of Strong Patent Position Despite ACLU Anti-Gene Patenting Lawsuit (GenomeWeb News)

by admin on March 3, 2010

Myriad Genetics doesn’t appear to be sweating over the outcome of its legal battle with the American Civil Liberties Union challenging the legality and constitutionality of seven of its patents on BRCA genes.

Previous post: Molecular diseases - Philippine Star

Next post: Myriad Assures Investors of Strong Patent Position Despite ACLU Anti-Gene … - GenomeWeb Daily News